Jeff Yass’s Sigilon Therapeutics, Inc. Common Stock SGTX Stock Holding History

Jeff Yass’s Portfolio SGTX Stock Details SGTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	–	Sell	-1,269	Closed	-$46K	–	14344
2021 Q4	$46K	Sell	1,269 -993	-44%	-$56.5K	﹤0.01%	12598
2021 Q3	$166K	Buy	+2,262	New	+$174K	﹤0.01%	11700

Other funds holding SGTX

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Jeff Yass's SGTX Position: Q2 2023 in Review

Jeff Yass sold out of Sigilon Therapeutics, Inc. Common Stock (SGTX) in Q2 2023, closing a stake of 11,031 shares — an estimated $80.1K sold.

Jeff Yass first reported a position in SGTX in Q3 2021 and held it in 7 quarters. The position peaked at $137K in Q3 2021. 16 funds tracked by Wall St. Rank hold SGTX as of Q2 2023.

Jeff Yass reported no remaining Sigilon Therapeutics, Inc. Common Stock position as of Q2 2023 after selling out during the quarter.
Jeff Yass sold 11,031 Sigilon Therapeutics, Inc. Common Stock shares in Q2 2023, an estimated $80.1K.
Jeff Yass first reported a position in Sigilon Therapeutics, Inc. Common Stock in Q3 2021 and held it in 7 quarters.
Jeff Yass's Sigilon Therapeutics, Inc. Common Stock position peaked at $137K in Q3 2021.
16 funds tracked by Wall St. Rank held Sigilon Therapeutics, Inc. Common Stock as of Q2 2023.

Based on Susquehanna International Group's 13F filing for Q2 2023, filed 11 Aug 2023.